Arlington Trust’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.23K Buy
40
+17
+74% +$2.11K ﹤0.01% 663
2026
Q2
$3.11K Hold
23
– – ﹤0.01% 614
2026
Q1
$4.13K Buy
+23
New +$3.93K ﹤0.01% 552
2025
Q1
– Sell
-184
Closed -$15.8K – 616
2024
Q4
$15.8K Hold
184
– – ﹤0.01% 437
2024
Q3
$17.4K Hold
184
– – ﹤0.01% 412
2024
Q2
$17.6K Hold
184
– – ﹤0.01% 410
2024
Q1
$24.2K Sell
184
-22
-11% -$2.71K 0.01% 324
2023
Q4
$29.8K Buy
+206
New +$28.3K 0.01% 320

Other funds holding ALB

Arlington Trust's ALB Position: Q3 2026 in Review

Arlington Trust increased its Albemarle (ALB) stake by 74% in Q3 2026, buying an estimated $2.11K and bringing the position to 40 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Arlington Trust first reported a position in ALB in Q4 2023 and has held it in 8 quarters since. The position peaked at $29.8K in Q4 2023. 169 funds tracked by Wall St. Rank hold ALB as of Q3 2026.

  • Arlington Trust held 40 shares of Albemarle worth $4.23K as of Q3 2026.
  • Arlington Trust bought 17 Albemarle shares in Q3 2026, an estimated $2.11K.
  • Albemarle made up ﹤0.01% of Arlington Trust's portfolio in Q3 2026, its #663 holding.
  • Arlington Trust first reported a position in Albemarle in Q4 2023 and has held it in 8 quarters since.
  • Arlington Trust's Albemarle position peaked at $29.8K in Q4 2023.
  • 169 funds tracked by Wall St. Rank held Albemarle as of Q3 2026.

Based on Arlington Trust's 13F filing for Q3 2026, filed 20 Oct 2026.